1. ATS/ERS/WASOG statement on sarcoidosis. American thoracic Society/European respiratory Society/World association of sarcoidosis and other granulomatous disorders;Hunninghake;Sarcoidosis Vasc Diffuse Lung Dis,1999
2. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them;Baughman;Sarcoidosis Vasc Diffuse Lung Dis,2008
3. Consensus conference: Activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8–11, 1993. Eur Respir J 1994;7:624–627.
4. 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab;Keijsers;Sarcoidosis Vasc Diffuse Lung Dis,2008
5. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis;Ziegenhagen;Eur Respir J,2003